Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer
NCT00553254
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma, Non Small Cell Lung
Interventions
DRUG:
PF-00299804
Sponsor
Pfizer